Liquidia (LQDA) Net Margin Growth (3y) (2023 - 2026)
Liquidia (LQDA) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 3,662.00 |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -98.00 |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -1,235.00 |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 11,401.00 |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 4,252.00 |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -404.00 |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -15,806.00 |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 3,232.00 |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -987.00 |
| 10 | Liquidia | 5.74 Bn | 5.52 Bn | 121.79 Mn | 24,977.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24,977.00 |
| Dec 31, 2025 | 13,770.00 |
| Sep 30, 2025 | 28,077.00 |
| Jun 30, 2025 | -22,939.00 |
| Mar 31, 2025 | -80,170.00 |
| Dec 31, 2024 | -96,053.00 |
| Sep 30, 2024 | -46,858.00 |
| Jun 30, 2024 | -58,942.00 |
| Mar 31, 2024 | -71,617.00 |
| Dec 31, 2023 | 156,912.00 |